Skip to main content

Nasopharengeal Pneumococcal Serotype Screening Assays: Completion, Testing, Validation, Scale-up and Market Launch

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Jun 27, 2016
Award amount: 
$75,000
Organization name: 
f(x) Immune Diagnostics, Inc.
Principal Investigator: 
Hickey, Michael H.
Grant program category: 
Business Financing
Grant program name: 
Company Inception Loan
Region: 
Western

f(x)'s Serotyping Assays allow rapid, economical determination of the types of Pneumococcal bacteria being carried in a population. This allows development and deployment of effective new vaccines against the the specific types of bacteria actually present in that population. Present methods require culturing, and are much slower, costlier to perform.

Fiscal year: 
2016